Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monopar Therapeutics

43.15
+1.333.18%
Post-market: 43.150.00000.00%19:28 EDT
Volume:9.74K
Turnover:414.24K
Market Cap:263.76M
PE:-10.49
High:43.78
Open:40.59
Low:40.59
Close:41.82
Loading ...

Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025

Insider Monkey
·
30 Apr

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

GlobeNewswire
·
29 Apr

Major Shareholder Sells Big Chunk of Monopar Therapeutics Stock!

TIPRANKS
·
05 Apr

Monopar Therapeutics downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
02 Apr

JonesTrading downgrades Monopar Therapeutics Inc (MNPR) to a Hold

TIPRANKS
·
02 Apr

Monopar Therapeutics Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Apr

Monopar Therapeutics Q4 EPS $(2.23) Down From $(0.60) YoY

Benzinga
·
31 Mar

Press Release: Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments

Dow Jones
·
31 Mar

Monopar Therapeutics Inc - to Submit Nda for Alxn1840 in Early 2026

THOMSON REUTERS
·
31 Mar

Monopar Therapeutics Inc - Q4 Net Loss of $2.23 per Share

THOMSON REUTERS
·
31 Mar

Monopar Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview

Reuters
·
24 Mar

Monopar Therapeutics Coverage Assumed by Piper Sandler at Overweight

Dow Jones
·
19 Mar

Monopar Therapeutics Appoints Quan Vu as New CFO

TIPRANKS
·
04 Mar

BRIEF-Monopar Therapeutics Inc Says On Feb 28, CFO Karthik Radhakrishnan’S Employment Terminated

Reuters
·
04 Mar

Monopar Therapeutics Inc Says on Feb 28, CFO Karthik Radhakrishnan’s Employment Terminated - SEC Filing

THOMSON REUTERS
·
04 Mar

Monopar Therapeutics Inc - Quan Vu Appointed as CFO Effective March 3, 2025

THOMSON REUTERS
·
04 Mar

Monopar Therapeutics Inc Says Karthik Radhakrishnan Will No Longer Serve as Co's CFO, Principal Financial Officer, or Principal Accounting Officer

THOMSON REUTERS
·
04 Mar

Monopar Therapeutics Appoints Lavina Talukdar to Board

TIPRANKS
·
25 Feb

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics

PR Newswire
·
24 Jan

Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright

TipRanks
·
23 Jan